Saturday, 19 October 2013

Actelion wins crucial FDA approval for next-gen lung disease drug Opsumit « New Drug Approvals

Actelion wins crucial FDA approval for next-gen lung disease drug Opsumit « New Drug Approvals:

'via Blog this'
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)